Dual-action therapies are emerging as a groundbreaking approach in the fight against both HIV and cancer. These treatments attack multiple pathways within disease mechanisms, offering {a{ promise of improved efficacy and reduced side effects compared to traditional single-target approaches. By integrating different therapeutic modalities, dual-acti